We are live on
!
Find out more
MCM
Matarin Capital Management Portfolio holdings
AUM
$409M
1-Year Est. Return
33.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$63.8M
(+6.3%)
Cap. Flow
+$34.9M
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
12.6%
Holding
322
New
38
Increased
152
Reduced
64
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$8.46M |
| 2 |
HA
Hawaiian Holdings, Inc.
HA
|
+$8.23M |
| 3 |
LM
Legg Mason, Inc.
LM
|
+$7.93M |
| 4 |
CHSP
Chesapeake Lodging Trust
CHSP
|
+$7.89M |
| 5 |
Coca-Cola Consolidated
COKE
|
+$7.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KCG
KCG Holdings, Inc.
KCG
|
+$9.43M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$8.69M |
| 3 |
ePlus
PLUS
|
+$8.06M |
| 4 |
Murphy USA
MUSA
|
+$7.57M |
| 5 |
Thor Industries
THO
|
+$7.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Industrials | 15.81% |
| 3 | Technology | 13.65% |
| 4 | Consumer Discretionary | 11.93% |
| 5 | Healthcare | 11.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Exelon
EXC
$47.3B
| $4.57M | 0.42% |
177,785
+24,751
| +16% | +$630K |
|
102
AbbVie
ABBV
$450B
| $4.55M | 0.42% |
+62,701
| New | +$4.22M |
|
103
Travelers Companies
TRV
$78.5B
| $4.51M | 0.42% |
35,678
+5,491
| +18% | +$676K |
|
104
Live Nation Entertainment
LYV
$41.9B
| $4.51M | 0.42% |
129,500
+27,826
| +27% | +$933K |
|
105
Synchrony
SYF
$24.8B
| $4.48M | 0.41% |
150,125
+50,497
| +51% | +$1.5M |
|
106
Cencora
COR
$59.9B
| $4.47M | 0.41% |
47,298
+6,654
| +16% | +$593K |
|
|
CIM
107
Chimera Investment
CIM
$1.08B
| $4.35M | 0.4% |
77,803
+6,609
| +9% | +$382K |
|
108
American Tower
AMT
$79.2B
| $4.34M | 0.4% |
32,762
+5,042
| +18% | +$646K |
|
|
AZPN
109
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $4.33M | 0.4% |
78,324
-5,601
| -7% | -$310K |
|
110
United Rentals
URI
$65.5B
| $4.3M | 0.4% |
+38,109
| New | +$4.25M |
|
|
GTY
111
Getty Realty Corp
GTY
$2.19B
| $4.29M | 0.4% |
171,106
-2,508
| -1% | -$64.3K |
|
112
1st Source
SRCE
$2.01B
| $4.23M | 0.39% |
88,256
+26,116
| +42% | +$1.23M |
|
|
JNPR
113
DELISTED
Juniper Networks
JNPR
| $4.22M | 0.39% |
151,330
+23,231
| +18% | +$675K |
|
114
LXP Industrial Trust
LXP
$3.45B
| $4.2M | 0.39% |
84,763
+1,475
| +2% | +$73.7K |
|
115
Silgan Holdings
SLGN
$4.99B
| $4.19M | 0.39% |
+131,713
| New | +$4.06M |
|
116
Keurig Dr Pepper
KDP
$42.1B
| $4.15M | 0.38% |
45,565
+6,989
| +18% | +$654K |
|
117
LyondellBasell Industries
LYB
$19.1B
| $4.14M | 0.38% |
49,064
+11,841
| +32% | +$983K |
|
118
McGrath RentCorp
MGRC
$2.9B
| $4.09M | 0.38% |
118,076
+925
| +0.8% | +$31.6K |
|
|
EE
119
DELISTED
El Paso Electric Company
EE
| $4.07M | 0.38% |
78,805
+8,368
| +12% | +$437K |
|
120
Republic Services
RSG
$68.4B
| $4.05M | 0.37% |
63,498
+9,731
| +18% | +$616K |
|
121
PNC Financial Services
PNC
$101B
| $4.03M | 0.37% |
+32,255
| New | +$3.89M |
|
122
ConocoPhillips
COP
$140B
| $4.03M | 0.37% |
91,580
+44,078
| +93% | +$2.06M |
|
123
Repligen
RGEN
$8.31B
| $4.02M | 0.37% |
96,965
+2,145
| +2% | +$81.5K |
|
|
FITB
124
Fifth Third Bancorp
FITB
$52.6B
| $4.02M | 0.37% |
154,756
+10,065
| +7% | +$249K |
|
125
Movado Group
MOV
$859M
| $3.87M | 0.36% |
153,370
+2,795
| +2% | +$64.5K |
|
Similar funds
GBBWRPM
PSSGI
RA
TAM
SIVVM
SM
NFG
AWW
Matarin Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Matarin Capital Management held 322 positions worth $1.08B, up 6.3% from $1.02B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management deployed $34.9M of net new capital in Q2 2017, opening 38 new positions and adding to 152 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Magellan Health Services, Inc., an estimated $8.69M trimmed.
- Matarin Capital Management's largest Q2 2017 buy was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
- Matarin Capital Management added most to Chesapeake Lodging Trust in Q2 2017, an estimated $7.89M increase.
- Matarin Capital Management's biggest Q2 2017 reduction was Magellan Health Services, Inc., cutting an estimated $8.69M.
- Matarin Capital Management fully exited KCG Holdings, Inc. in Q2 2017, selling an estimated $9.43M.
- Matarin Capital Management's ten largest holdings make up 13% of its $1.08B portfolio in Q2 2017.
- Matarin Capital Management opened 38 new positions and closed 47 in Q2 2017.
- Matarin Capital Management's portfolio value rose 6.3% quarter-over-quarter to $1.08B.
Based on Matarin Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.